Allogene Therapeutics, Inc. · NASDAQ:ALLO

Lynx1 Capital Management LP reported a 5.20% stake in Allogene Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 14, 2025

Lynx1 Capital Management LP reported a 5.20% stake in Allogene Therapeutics, Inc., 10,874,723 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).

Stake
5.20%
Shares
10,874,723
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Lynx1 Capital Management LP5.20%10,874,723
Weston Nichols5.20%10,874,723

Source

View original at SEC

Related